These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28521962)

  • 1. The functional roles of PML nuclear bodies in genome maintenance.
    Chang HR; Munkhjargal A; Kim MJ; Park SY; Jung E; Ryu JH; Yang Y; Lim JS; Kim Y
    Mutat Res; 2018 May; 809():99-107. PubMed ID: 28521962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of PML-I in reformation of PML nuclear bodies in acute promyelocytic leukemia cells by leptomycin B.
    Wang C; Su L; Shao YM; Chen WZ; Bu N; Hao R; Ma LY; Hussain L; Lu XY; Wang QQ; Naranmandura H
    Toxicol Appl Pharmacol; 2019 Dec; 384():114775. PubMed ID: 31669778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promyelocytic leukemia nuclear bodies support a late step in DNA double-strand break repair by homologous recombination.
    Yeung PL; Denissova NG; Nasello C; Hakhverdyan Z; Chen JD; Brenneman MA
    J Cell Biochem; 2012 May; 113(5):1787-99. PubMed ID: 22213200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PML nuclear body disruption impairs DNA double-strand break sensing and repair in APL.
    di Masi A; Cilli D; Berardinelli F; Talarico A; Pallavicini I; Pennisi R; Leone S; Antoccia A; Noguera NI; Lo-Coco F; Ascenzi P; Minucci S; Nervi C
    Cell Death Dis; 2016 Jul; 7(7):e2308. PubMed ID: 27468685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice.
    Voisset E; Moravcsik E; Stratford EW; Jaye A; Palgrave CJ; Hills RK; Salomoni P; Kogan SC; Solomon E; Grimwade D
    Blood; 2018 Feb; 131(6):636-648. PubMed ID: 29191918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase separation of PML/RARα and BRD4 coassembled microspeckles governs transcriptional dysregulation in acute promyelocytic leukemia.
    Zhang Y; Lou J; Liu Y; Jin P; Tan Y; Song H; Jin W; Wang D; Dong F; Wu S; Fang H; Chen S; Chen Z; Wang K
    Proc Natl Acad Sci U S A; 2024 Aug; 121(34):e2406519121. PubMed ID: 39136995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Involvement of PML proteins in treatment of acute promyelocytic leukemia with arsenic trioxide].
    Hao R; Su L; Shao Y; Bu N; Ma L; Naranmandura H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(5):541-551. PubMed ID: 30693698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of arsenic on the topology and solubility of promyelocytic leukemia (PML)-nuclear bodies.
    Hirano S; Udagawa O
    PLoS One; 2022; 17(5):e0268835. PubMed ID: 35594310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the promyelocytic leukemia protein without the nuclear localization signal as a novel diagnostic marker for acute promyelocytic leukemia.
    Xu T; Yang XQ; Jiang KL; Wang H; Ma PP; Zhong L; Liu BZ
    Oncol Rep; 2017 Feb; 37(2):986-994. PubMed ID: 28075463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deneddylation of PML/RARα reconstructs functional PML nuclear bodies via orchestrating phase separation to eradicate APL.
    Shao X; Chen Y; Xu A; Xiang D; Wang W; Du W; Huang Y; Zhang X; Cai M; Xia Z; Wang Y; Cao J; Zhang Y; Yang B; He Q; Ying M
    Cell Death Differ; 2022 Aug; 29(8):1654-1668. PubMed ID: 35194189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of nuclear bodies in apoptosis signalling.
    Krieghoff-Henning E; Hofmann TG
    Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 and p21(Waf1) are recruited to distinct PML-containing nuclear foci in irradiated and Nutlin-3a-treated U2OS cells.
    Shen H; Maki CG
    J Cell Biochem; 2010 Dec; 111(5):1280-90. PubMed ID: 20803550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PML nuclear body-residing proteins sequentially associate with HPV genome after infectious nuclear delivery.
    Guion L; Bienkowska-Haba M; DiGiuseppe S; Florin L; Sapp M
    PLoS Pathog; 2019 Feb; 15(2):e1007590. PubMed ID: 30802273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation.
    Wang QQ; Zhou XY; Zhang YF; Bu N; Zhou J; Cao FL; Naranmandura H
    Oncotarget; 2015 Sep; 6(28):25646-59. PubMed ID: 26213848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence.
    Li K; Wang F; Cao WB; Lv XX; Hua F; Cui B; Yu JJ; Zhang XW; Shang S; Liu SS; Yu JM; Han MZ; Huang B; Zhang TT; Li X; Jiang JD; Hu ZW
    Cancer Cell; 2017 May; 31(5):697-710.e7. PubMed ID: 28486108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
    Duprez E; Lillehaug JR; Naoe T; Lanotte M
    Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PML nuclear bodies in the pathogenesis of acute promyelocytic leukemia: active players or innocent bystanders?
    Brown NJ; Ramalho M; Pedersen EW; Moravcsik E; Solomon E; Grimwade D
    Front Biosci (Landmark Ed); 2009 Jan; 14(5):1684-707. PubMed ID: 19273155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains.
    Grignani F; Testa U; Rogaia D; Ferrucci PF; Samoggia P; Pinto A; Aldinucci D; Gelmetti V; Fagioli M; Alcalay M; Seeler J; Grignani F; Nicoletti I; Peschle C; Pelicci PG
    EMBO J; 1996 Sep; 15(18):4949-58. PubMed ID: 8890168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear p62 condensates stabilize the promyelocytic leukemia nuclear bodies by sequestering their ubiquitin ligase RNF4.
    Fu A; Luo Z; Ziv T; Bi X; Lulu-Shimron C; Cohen-Kaplan V; Ciechanover A
    Proc Natl Acad Sci U S A; 2024 Oct; 121(43):e2414377121. PubMed ID: 39418304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PML Nuclear bodies: the cancer connection and beyond.
    Abou-Ghali M; Lallemand-Breitenbach V
    Nucleus; 2024 Dec; 15(1):2321265. PubMed ID: 38411156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.